SCHEMBL21055097

SCHEMBL21055097

COc1cc2ccc(CC(C)C)cc2cc1OC

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.50
ALOX12 P18054 3/20 0.50
FOS P01100 1/20 0.46
TTR P02766 1/20 0.46
JUN P05412 1/20 0.46
NR3C1 P04150 1/20 0.46
HSD17B1 P14061 1/20 0.46
HSD17B2 P37059 1/20 0.46
CYP1A2 P05177 1/20 0.45
LDHA P00338 1/20 0.45
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
HTR2B P41595 1/20 0.44
CA2 P00918 1/20 0.42
PDE10A Q9Y233 2/20 0.42
PDGFRB P09619 1/20 0.42
PDGFRA P16234 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRB2 P47870 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11282729 0.84 HTR2A (0.62) HTR2AHTR2CHTR2B
SCHEMBL28292686 0.84 HTR2A (0.57) CYP1A2HTR2AHTR2CHTR2BGABRA1
SCHEMBL13484112 0.83 PTGS1 (0.54) CYP1A2
SCHEMBL806723 0.82 CA2 (0.63) ALOX15ALOX12FOSTTRJUN
SCHEMBL11405537 0.79 HTR2A (0.63) CYP1A2HTR2AHTR2CHTR2BGABRA1
SCHEMBL25628335 0.79 CYP1A2 (0.57) CYP1A2CA2PDE10APDGFRBPDGFRA
SCHEMBL20821072 0.78 ALOX15 (0.80) ALOX15ALOX12FOSTTRJUN
SCHEMBL6336756 0.77 TTR (0.57) TTRCYP1A2CA2PDE10APDGFRB
SCHEMBL6348328 0.77 KDM4E (0.48) CYP1A2CA2PDE10APDGFRBPDGFRA
SCHEMBL5678180 0.77 PDE4A (0.59) TTRCYP1A2CA2PDE10APDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019113312-A1 ANTICANCER COMPOUND PROCESS INNOCRIN PHARMACEUTICALS, INC. (US) 2019-06-13 WO disclosed